NEW YORK (GenomeWeb) – Stratos Genomics has raised $10 million toward a Series B financing round targeting $16.3 million.

The Seattle-based firm disclosed the raise in a Form D filed with the US Securities and Exchange Commission on Monday. In an email to GenomeWeb Daily News, Stratos Chairman and CEO Alan Stephan said the $10 million is the first close of a Series B round. He declined to comment further, saying more information will be released after the second close is completed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.